- Home
- Publications
- Publication Search
- Publication Details
Title
New progress in drugs treatment of diabetic kidney disease
Authors
Keywords
Diabetic kidney disease, Treatment, New drugs
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 141, Issue -, Pages 111918
Publisher
Elsevier BV
Online
2021-07-20
DOI
10.1016/j.biopha.2021.111918
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renoprotective Effects of DPP-4 Inhibitors
- (2021) Daiji Kawanami et al. Antioxidants
- Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
- (2020) Saleela M Ruwanpura et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY
- (2020) Jinnie J. Rhee et al. DIABETES OBESITY & METABOLISM
- Effects of ACE Inhibitors and Angiotensin Receptor Blockers in Normotensive Patients with Diabetic Kidney Disease
- (2020) Dandan He et al. HORMONE AND METABOLIC RESEARCH
- Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
- (2020) Priscila Calle et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Atherogenic dyslipidemia and diabetic nephropathy
- (2020) Giuseppina Russo et al. JOURNAL OF NEPHROLOGY
- Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
- (2020) Marta Ruiz-Ortega et al. Journal of Clinical Medicine
- Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
- (2020) Lijun Zhao et al. Frontiers in Cell and Developmental Biology
- 1,25(OH)2D3 provides protection against diabetic kidney disease by downregulating the TLR4-MyD88-NF-κB pathway
- (2020) Ping Liu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
- (2020) Alessandro Doria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
- (2020) Kachonsak Yongwatana et al. Journal of Diabetes Research
- GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
- (2020) Daiji Kawanami et al. Frontiers in Pharmacology
- Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)
- (2020) Masaomi Nangaku et al. Kidney International Reports
- Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
- (2020) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury
- (2020) Jun Su et al. MOLECULAR BIOLOGY REPORTS
- Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
- (2020) Carolyn F. Deacon Nature Reviews Endocrinology
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases
- (2020) Ayano Kubo et al. BMC Nephrology
- A Prospective Single-Blind Randomized Trial of Ramipril, Eplerenone and Their Combination in Type 2 Diabetic Nephropathy
- (2020) Mostafa El Mokadem et al. CardioRenal Medicine
- Mineralocorticoid Receptor Antagonists: a Comprehensive Review of Finerenone
- (2020) Juan Simon Rico-Mesa et al. Current Cardiology Reports
- Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2/STAT3/SOCS1 pathway in streptozotocin-induced diabetic rats
- (2020) Maolin Zhu et al. LIFE SCIENCES
- Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
- (2020) David C Wheeler et al. Lancet Diabetes & Endocrinology
- Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: individual effects of treatment
- (2019) Emilie H. Zobel et al. DIABETES OBESITY & METABOLISM
- Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
- (2019) Carolyn F. Deacon Frontiers in Endocrinology
- Using DPP-4 inhibitors to modulate beta cell function in type 1 diabetes and in the treatment of diabetic kidney disease
- (2019) Hugh Davis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mineralocorticoid Antagonism and Diabetic Kidney Disease
- (2019) Yuliya Lytvyn et al. Current Diabetes Reports
- Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program
- (2019) Gemma A. Figtree et al. CIRCULATION
- Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
- (2019) Yanhuan Feng et al. American Journal of Cardiovascular Drugs
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pirfenidone prevents acute kidney injury in the rat
- (2019) Ixchel Lima-Posada et al. BMC Nephrology
- Class effect for SGLT-2 inhibitors: a tale of 9 drugs
- (2019) Dario Giugliano et al. Cardiovascular Diabetology
- Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
- (2019) Annabelle M. Warren et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation
- (2019) Min-Kyun Song et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Role of Vitamin D Status in Diabetic Patients with Renal Disease
- (2019) Guido Gembillo et al. Medicina-Lithuania
- GLP-1 Receptor Agonists and Kidney Protection
- (2019) Eulalia Valentina Greco et al. Medicina-Lithuania
- GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials
- (2019) Dario Giugliano et al. DIABETES OBESITY & METABOLISM
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Coixol amplifies glucose-stimulated insulin secretion via cAMP mediated signaling pathway
- (2019) Abdul Hameed et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program
- (2019) Brendon L. Neuen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Selonsertib in Patients with Diabetic Kidney Disease
- (2019) Glenn M. Chertow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Rajiv Agarwal et al. LANCET
- Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- Use of Paricalcitol as Adjunctive Therapy to Renin-Angiotensin-Aldosterone System Inhibition for Diabetic Nephropathy: A Systematic Review of the Literature
- (2019) Alexandra Schuster et al. CLINICAL THERAPEUTICS
- Progress in the Mechanism and Clinical Application of Cilostazol
- (2019) Huilei Zheng et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease
- (2019) Dou et al. Toxins
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease
- (2019) Fengjuan Huang et al. EBioMedicine
- Endothelin: 30 Years From Discovery to Therapy
- (2019) Matthias Barton et al. HYPERTENSION
- TGF-β1 – A truly transforming growth factor in fibrosis and immunity
- (2019) Monika Lodyga et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Glomerular podocytes in diabetic renal disease
- (2019) Paweł Podgórski et al. Advances in Clinical and Experimental Medicine
- SGLT2 inhibitors to prevent diabetic kidney disease
- (2019) Paola Fioretto et al. Lancet Diabetes & Endocrinology
- SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review
- (2018) Radica Z. Alicic et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
- (2018) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy
- (2018) Jian Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TGF-β1/p53 signaling in renal fibrogenesis
- (2018) Stephen P. Higgins et al. CELLULAR SIGNALLING
- Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
- (2018) Juan F. Navarro-González et al. DIABETES CARE
- Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials
- (2018) Lennart Tonneijck et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study
- (2018) Paola Fioretto et al. DIABETES OBESITY & METABOLISM
- Inhibitors of phosphodiesterase as cancer therapeutics
- (2018) Ting Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tranilast inhibits interleukin-33 production by macrophages
- (2018) Sachiko Hiraide et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diabetic nephropathy: Is there a role for oxidative stress?
- (2018) Manpreet K. Sagoo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
- (2018) Akira Mima JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial
- (2018) PLGC Liyanage et al. Journal of Postgraduate Medicine
- Update of pathophysiology and management of diabetic kidney disease
- (2018) Yi-Chih Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury
- (2018) Quan Hong et al. KIDNEY INTERNATIONAL
- The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling
- (2018) Jonatan Barrera-Chimal et al. KIDNEY INTERNATIONAL
- Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials
- (2018) Huan-gao Zhu et al. Lipids in Health and Disease
- Mitochondrial dysfunction in diabetic kidney disease
- (2018) Josephine M. Forbes et al. Nature Reviews Nephrology
- Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease
- (2018) Vincenzo Bellizzi et al. BMC Nephrology
- Cellular death, reactive oxygen species (ROS) and diabetic complications
- (2018) Caroline Maria Oliveira Volpe et al. Cell Death & Disease
- A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies
- (2018) Munehiro Kitada et al. Nutrients
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Novel therapies for diabetic kidney disease
- (2018) David Z.I. Cherney et al. Kidney International Supplements
- Mineralocorticoid Receptor and Cardiovascular Disease
- (2018) Mathieu Buonafine et al. AMERICAN JOURNAL OF HYPERTENSION
- RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy
- (2018) Zongshun Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone Deacetylase Inhibitors and Diabetic Kidney Disease
- (2018) Mitchell Hadden et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ASK1 contributes to fibrosis and dysfunction in models of kidney disease
- (2018) John T. Liles et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
- (2018) Srinivasan Beddhu et al. Journal of the American Heart Association
- Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs)
- (2018) Malgorzata Teodorowicz et al. Frontiers in Immunology
- ROLE OF VITAMIN D AND ITS ANALOGUES IN DIABETIC NEPHROPATHY: A META-ANALYSIS
- (2018) Sonali Gupta et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- New insights on the renal protective effects of mineralocorticoid receptor antagonists
- (2018) Giuseppe Maiolino et al. JOURNAL OF HYPERTENSION
- Histone demethylase UTX is a therapeutic target for diabetic kidney disease
- (2018) Hong Chen et al. JOURNAL OF PHYSIOLOGY-LONDON
- RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
- (2018) Sandor Koszegi et al. JOURNAL OF PHYSIOLOGY-LONDON
- Glomerular mesangial cell and podocyte injuries in diabetic nephropathy
- (2018) Chun-Wu Tung et al. NEPHROLOGY
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME® trial
- (2018) Takashi Kadowaki et al. Journal of Diabetes Investigation
- The impact of liraglutide on the JAK-STAT pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells
- (2018) Tali Zitman-Gal et al. Journal of Diabetes
- Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment
- (2018) Ana Beatriz Vargas-Santos et al. JAMA Internal Medicine
- Managing chronic kidney disease in diabetes patients with the latest chemical therapies
- (2018) Jingbo Hu et al. Expert Review of Clinical Pharmacology
- Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
- (2018) Heng Li et al. Frontiers in Pharmacology
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential
- (2017) Dongqing Zha et al. ENDOCRINOLOGY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4
- (2017) Junwei Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Novel avenues for treating diabetic nephropathy: new investigational drugs
- (2017) Viviana Lacava et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes
- (2017) Lea Duvnjak et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy
- (2017) Shigehiro Katayama et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy
- (2017) Yong-Chao Qiao et al. MEDICINE
- Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis
- (2017) Zhenzhen Li et al. NEPHROLOGY
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats
- (2017) Osama Mahmoud Mehanna et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
- (2017) David Z I Cherney et al. Lancet Diabetes & Endocrinology
- Normoalbuminuric diabetic kidney disease
- (2017) Chao Chen et al. Frontiers of Medicine
- Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc
- (2017) Shikun Yang et al. Redox Biology
- Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease
- (2016) Vasilios Papademetriou et al. AMERICAN JOURNAL OF NEPHROLOGY
- Therapeutic potential of endothelin receptor antagonism in kidney disease
- (2016) Alicja Czopek et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System BlockadeHighlights
- (2016) Sang-Man Jin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Pleiotropic effects of vitamin D in chronic kidney disease
- (2016) Wen-Chih Liu et al. CLINICA CHIMICA ACTA
- Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade
- (2016) P. M. Palevsky et al. Clinical Journal of the American Society of Nephrology
- Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS
- (2016) Jan H. Cornel et al. DIABETES CARE
- Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
- (2016) Ofri Mosenzon et al. DIABETES CARE
- JAK inhibition in the treatment of diabetic kidney disease
- (2016) Frank C. Brosius et al. DIABETOLOGIA
- Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
- (2016) Hiddo J. L. Heerspink et al. DIABETOLOGIA
- Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
- (2016) Niloy Bhattacharjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
- (2016) Asma S. AL-Onazi et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
- (2016) W. Scheele et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
- (2016) Agnieszka Loboda et al. MEDIATORS OF INFLAMMATION
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of a multidisciplinary self-care management program on quality of life, self-care, adherence to anti-hypertensive therapy, glycemic control, and renal function in diabetic kidney disease: A Cross-over Study Protocol
- (2016) Nancy Helou et al. BMC Nephrology
- ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy
- (2016) Hui Peng et al. Scientific Reports
- Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial
- (2016) Morten Lindhardt et al. BMJ Open
- Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease
- (2016) Alejandra Guillermina Miranda-Díaz et al. Journal of Diabetes Research
- Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial
- (2016) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial
- (2015) Katherine R. Tuttle et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
- (2015) Mark E. Cooper et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Sevelamer Carbonate on Advanced Glycation End Products and Antioxidant/Pro-Oxidant Status in Patients with Diabetic Kidney Disease
- (2015) E. M. Yubero-Serrano et al. Clinical Journal of the American Society of Nephrology
- Serum Uric Acid and Risk of CKD in Type 2 Diabetes
- (2015) S. De Cosmo et al. Clinical Journal of the American Society of Nephrology
- Impact of Lifestyle Modification on Diabetic Kidney Disease
- (2015) Chijoke Onyenwenyi et al. Current Diabetes Reports
- ASK1 Inhibitor Halts Progression of Diabetic Nephropathy inNos3-Deficient Mice
- (2015) Greg H. Tesch et al. DIABETES
- Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
- (2015) Meng Lv et al. DRUG DISCOVERY TODAY
- Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone
- (2015) Mitja Lainscak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Phosphodiesterase type 5 inhibitors and kidney disease
- (2015) Baris Afsar et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists
- (2015) Samantha Dias Suthar et al. SEMINARS IN DIALYSIS
- Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study
- (2015) Hanyu Zhu et al. Journal of Diabetes
- Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
- (2015) Bancha Satirapoj et al. Journal of Diabetes Research
- Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
- (2015) Stephanie Toth-Manikowski et al. Journal of Diabetes Research
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- Endothelin Blockade in Diabetic Kidney Disease
- (2015) Lidia Anguiano et al. Journal of Clinical Medicine
- Oxidative DNA Damage in Kidneys and Heart of Hypertensive Mice Is Prevented by Blocking Angiotensin II and Aldosterone Receptors
- (2015) Susanne Brand et al. PLoS One
- Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
- (2014) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials
- (2014) Sébastien Champion et al. Cardiovascular Therapeutics
- Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study
- (2014) Peng Liu et al. CLINICAL ENDOCRINOLOGY
- Role of Transcription Factor Acetylation in Diabetic Kidney Disease
- (2014) R. Liu et al. DIABETES
- Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
- (2014) Karen L. Margolis et al. DIABETES CARE
- Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial
- (2014) Carmine Zoccali et al. HYPERTENSION
- Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension
- (2014) C S Oxlund et al. JOURNAL OF HUMAN HYPERTENSION
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
- (2014) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of glucose and blood pressure control on diabetic kidney disease in old patients with type 2 diabetes
- (2014) Tzu-En Wu et al. Diabetology & Metabolic Syndrome
- Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals
- (2014) Jennifer E. Ho et al. Journal of the American Heart Association
- ALTITUDE Trial and Dual RAS Blockade: The Alluring but Soft Science of the Surrogate End Point
- (2013) Franz H. Messerli et al. AMERICAN JOURNAL OF MEDICINE
- Probucol Inhibited Nox2 Expression and Attenuated Podocyte Injury in Type 2 Diabetic Nephropathy of db/db Mice
- (2013) Guangyu Zhou et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Regulation of STAT signaling by acetylation
- (2013) Shougang Zhuang CELLULAR SIGNALLING
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- Targeting of Rho Kinase Ameliorates Impairment of Diabetic Endothelial Function in Intrarenal Artery
- (2013) Hongping Yin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α
- (2013) Keiichiro Matoba et al. KIDNEY INTERNATIONAL
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy
- (2013) Xi Xie et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
- (2013) Nancy J. Brown Nature Reviews Nephrology
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update
- (2013) Mandeep Kumar Arora et al. VASCULAR PHARMACOLOGY
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline
- (2012) Yelena Slinin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Update on Potential Drugs for the Treatment of Diabetic Kidney Disease
- (2012) Brian Shepler et al. CLINICAL THERAPEUTICS
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amelioration of Albuminuria in ROCK1 Knockout Mice with Streptozotocin-Induced Diabetic Kidney Disease
- (2011) Li Zhou et al. AMERICAN JOURNAL OF NEPHROLOGY
- Vitamin D
- (2011) Yan C. Li CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
- (2011) G. Zoppini et al. DIABETES CARE
- Glycemic Control, Complications, and Death in Older Diabetic Patients: The Diabetes and Aging Study
- (2011) E. S. Huang et al. DIABETES CARE
- The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial
- (2011) A. Rafnsson et al. DIABETOLOGIA
- New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
- (2011) Michael B. Sporn et al. JOURNAL OF NATURAL PRODUCTS
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus
- (2011) George L. Bakris MAYO CLINIC PROCEEDINGS
- Pathogenesis of diabetic nephropathy
- (2011) Zemin Cao et al. Journal of Diabetes Investigation
- The Role of Heparanase in Diseases of the Glomeruli
- (2010) Maciej Szymczak et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Phosphodiesterase inhibitors in the management of autoimmune disease
- (2010) Padmanabha Shenoy et al. AUTOIMMUNITY REVIEWS
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- Dual Renin-Angiotensin-Aldosterone System Blockade for Diabetic Kidney Disease
- (2010) Raimund H. Pichler et al. Current Diabetes Reports
- Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
- (2010) L. N. Broekhuizen et al. DIABETOLOGIA
- Sitagliptin reduces albuminuria in patients with type 2 diabetes [Rapid Communication]
- (2010) Sachiko Hattori ENDOCRINE JOURNAL
- Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure
- (2010) Radko Komers et al. KIDNEY INTERNATIONAL
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Evaluation of role of doxycycline (a matrix metalloproteinase inhibitor) on renal functions in patients of diabetic nephropathy
- (2010) Hari Krishan Aggarwal et al. RENAL FAILURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started